Tiamulin Fumarate - QILU PHARMACEUTICAL HULUN BUIR BRANCH
- Manufacturer
- QILU PHARMACEUTICAL HULUN BUIR BRANCH
- Effective date
- 2026-10-12
- Label type
- BULK INGREDIENT - ANIMAL DRUG
- Version
- 4
- Source
- daily-update
- Hydrated at
- 2026-10-15 01:03:04
Label at a glance#
ProductTiamulin Fumarate
Active ingredientTIAMULIN FUMARATE, Neomycin Sulfate
Label structure2 sections
Label contents#
Full prescribing information#
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
Products#
Every source-derived product name is available through these pages.
- Tiamulin Fumarate
- TIAMULIN
- Neomycin Sulfate
- NEOMYCIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 86191-017 | 86191-017-01 |
| 86191-032 | 86191-032-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TIAMULIN FUMARATE | ION1Q02ZCX | ACTIB |
| Neomycin Sulfate | 057Y626693 | ACTIB |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2024-08-09 | full-release | 2026-06-01 02:51:07 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

